<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02460328</url>
  </required_header>
  <id_info>
    <org_study_id>794/2557(EC4)</org_study_id>
    <nct_id>NCT02460328</nct_id>
  </id_info>
  <brief_title>Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome</brief_title>
  <official_title>Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Evaluate about age of resolution in immune defect in 22q11.2 Deletion Syndrome

        -  Incidence of immunodeficiencies in 22q11.2 Deletion Syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      22q11.2 Deletion Syndrome is the most common for microdeletion syndrome. The incidence is
      about 1:4000 of live birth. Clinical features in this syndrome are vary which consist of
      conotruncal cardiac anomalies, developmental disabilities, palatal anomalies, speech delay,
      hypocalcemia, characteristic facial features and immunodeficiencies. The most common type of
      immunodeficiencies is T cell defect that associated with thymic hypoplasia. In the present
      time, the investigators don't know about the resolution of immune defect in this syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>age of resolution in immune defect in 22q11.2 Deletion Syndrome</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of immunodeficiencies in 22q11.2 Deletion Syndrome</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of infectious disease in 22q11.2 Deletion Syndrome</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">43</enrollment>
  <condition>Immune Defect</condition>
  <condition>22q11.2 Deletion Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        22q11.2 deletion syndrome diagnosed from Fluorescence in situ hybridization (FISH) for
        22q11
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  22q11.2 deletion syndrome patients in allergy and immunology clinic, genetic clinic,
             cardio clinic, genetic clinic and development clinic

        Exclusion Criteria:

          -  loss follow up in 22q11.2 deletion syndrome patients or incomplete medical record
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Punchama Pacharn, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008 Aug;122(2):362-7, 367.e1-4. doi: 10.1016/j.jaci.2008.03.033. Epub 2008 May 16.</citation>
    <PMID>18485468</PMID>
  </reference>
  <results_reference>
    <citation>Chinen J, Rosenblatt HM, Smith EO, Shearer WT, Noroski LM. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol. 2003 Mar;111(3):573-9.</citation>
    <PMID>12642839</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>DiGeorge Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

